Nonetheless, although this latter hypothesis must be confirmed by further studies, we demonstrated that NDRG1 has a role in tumor progression led by the TGFβ signaling pathway to modulate EMT, metastatic and tumor-initiating abilities, and distinct CSC populations at different stages of tumor progression. This evidence concerns the gene NDRG1 and neoplasm.